申请人:MERRELL DOW PHARMACEUTICALS INC.
公开号:EP0079050A1
公开(公告)日:1983-05-18
This invention relates to aroyl-2-imidazolidinones of the following general structure which are useful as cardiotonics and antihypertensive agents
wherein Ar is furanyl, thienyl, 1H-pyrrolyl, or phenyl optionally substituted with one or two X groups; X is halogen, hydroxy, lower alkyl, lower alkoxy, lower alkylthio, lower alkylsulfoxide, lower alkylsulphone, trifluoromethyl, -SO2N(R2)2. NR3,R4, pyrrolidino, piperidino, morpholino, piperazino or N'-alkyl-piperazino; R is hydrogen, lower alkyl, lower alkylcarbonyl or benzoyl; each of R1, Rz, R3 and R4 is hydrogen or lower alkyl; T is an oxygen atom or a divalent sulfur atom; and the pharmaceutically acceptable salts thereof.
本发明涉及具有下列一般结构的甲酰基-
2-咪唑烷酮,可用作强心剂和降压药
其中 Ar 是
呋喃基、
噻吩基、1H-
吡咯基或任选被一个或两个 X 基团取代的苯基;X 是卤素、羟基、低级烷基、低级烷氧基、低级烷
硫基、低级烷基亚砜、低级烷基砜、三
氟甲基、-SO2N(R2)2.NR3、R4、
吡咯烷基、
哌啶基、吗啉基、
哌嗪基或 N'-烷基-
哌嗪基;R 是氢、低级烷基、低级烷基羰基或苯甲酰基;R1、Rz、R3 和 R4 中的每一个都是氢或低级烷基;T 是氧原子或二价
硫原子;以及它们的药学上可接受的盐。